Loading clinical trials...
Loading clinical trials...
Denosumab vs Alendronate in Patients With Osteoporotic Vertebral Compression Fracture After Percutaneous Vertebroplasty: A Randomized Controlled Trial
Conditions
Interventions
Denosumab
Alendronate
+1 more
Locations
1
China
Shenzhen People's Hospital
Shenzhen, Guangdong, China
Start Date
January 3, 2021
Primary Completion Date
September 20, 2023
Completion Date
October 25, 2023
Last Updated
February 21, 2023
Lead Sponsor
Shenzhen People's Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions